title: Complete remission of diffuse hepatocellular carcinoma in a young adult after GSP-TACE: a case report.
abstract: Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver. It mostly occurs in older age groups (usually those 50 to 60 years old), and rarely in young adults. The survival rate of these young HCC patients is usually very low. The authors report a case of a 22-year old man with diffuse-type HCC who successfully achieved complete remission for 46 months after second transcatheter arterial chemoembolization using gelatin sponge particles (Eric Kang Pharmaceutical Technology Co., Ltd. Hangzhou, China) combined with pirarubicin.
authors.forename: Song
authors.initials: S
authors.lastname: Liu
authors.affiliation: Department of Interventional Radiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, P,R, China. zhangyuewei1121@163.com.
authors.forename: Yuewei
authors.initials: Y
authors.lastname: Zhang
authors.forename: Guangsheng
authors.initials: G
authors.lastname: Zhao
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D016461:Chemoembolization, Therapeutic; D005781:Gelatin Sponge, Absorbable; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D012074:Remission Induction; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents